"UK Patients First to Receive Experimental mRNA Cancer Therapy"

Patients in the UK have received an experimental mRNA therapy for melanoma, lung cancer, and other solid tumors at Hammersmith hospital in London. The therapy aims to present tumor markers to the immune system, helping it recognize and fight cancer cells. The trial, known as Mobilize, will assess the therapy's safety and effectiveness, administered alone or in combination with pembrolizumab. Researchers hope this approach may lead to a new treatment option for difficult-to-treat cancers, addressing the need for less toxic and more precise anti-cancer therapies.